Niacin vs Niacinamide vs Inositol Hexanicotinate: Flushing, Forms, and Uses

All three forms supply vitamin B3, but they behave differently in the body and carry different safety profiles. Understanding those differences helps you have a more informed conversation with your clinician before choosing a supplement.

What Is Vitamin B3 and Why Does It Matter?

Vitamin B3 is a water-soluble nutrient the body uses to make NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleotide phosphate). According to the NIH Office of Dietary Supplements (ODS), NAD serves as a coenzyme required by more than 400 enzymes, more than for any other vitamin-derived coenzyme. That is a substantial biochemical footprint.

The ODS describes two broad categories of function. First, NAD supports catabolic redox reactions that transfer energy from carbohydrates, fats, and proteins to ATP, the cell's primary energy currency. Second, as NADP, it enables anabolic reactions such as the synthesis of cholesterol and fatty acids. In short, vitamin B3 is central to both breaking things down and building things up at the cellular level.

Reference Intakes: How Much Do Adults Need?

The NIH ODS reports the following Dietary Reference Intake values, drawn from the National Academies of Sciences, Engineering, and Medicine:

• Recommended Dietary Allowance (RDA): 16 mg niacin equivalents (NE) per day for adult men and 14 mg NE per day for adult women.
• Tolerable Upper Intake Level (UL): 35 mg per day for adults 19 and older from supplemental sources.

The UL applies to supplemental nicotinic acid and nicotinamide. It does not apply to niacin naturally present in food, which the ODS notes is safe and has no reported adverse effects. It also does not apply to individuals receiving niacin under medical supervision.

The Three Main Forms

Nicotinic Acid (Niacin)

Nicotinic acid is the form most studied at pharmacologic doses. At the supplemental doses most people encounter, it functions as a standard B3 source. At doses in the thousands of milligrams per day, it has been used medically to influence blood lipid profiles. The ODS grades the lipid evidence as strong: high-dose nicotinic acid raises HDL and lowers LDL, triglycerides, and lipoprotein(a). However, the ODS grades the evidence that nicotinic acid supplementation reduces the risk of cardiovascular events as insufficient, meaning current data do not firmly establish a clinical benefit on outcomes.

The most well-known side effect of nicotinic acid is skin flushing, a sensation of warmth, redness, and tingling that typically affects the face and upper body. This is why the supplemental UL is set at 35 mg per day. Pharmacologic doses in the thousands of milligrams should only be taken with medical approval and monitoring. The ODS is explicit that at those levels, nicotinic acid acts as a drug, not a supplement.

Nicotinamide (Niacinamide)

Nicotinamide is the amide form of niacin. It is also converted to NAD in the body and therefore supports the same core enzymatic functions described above. Crucially, nicotinamide does not cause the skin flushing associated with nicotinic acid, which makes it a common choice in supplements and topical skincare products.

The same supplemental UL of 35 mg per day cited by the ODS applies to nicotinamide as well. At doses above the UL, side effects including nausea and liver stress have been reported in the literature, though the threshold differs from nicotinic acid. For personal dosing guidance, consult a clinician or pharmacist.

Inositol Hexanicotinate (Flush-Free Niacin)

Inositol hexanicotinate is sometimes marketed as flush-free niacin because it does not reliably produce the skin flushing reaction. It consists of six nicotinic acid molecules bound to an inositol molecule. The theoretical rationale is that slow release of nicotinic acid from the compound avoids the rapid peak that triggers flushing.

However, research on whether inositol hexanicotinate actually delivers meaningful amounts of free nicotinic acid into the bloodstream is limited and mixed. The NIH ODS does not currently endorse it as a proven equivalent to nicotinic acid for lipid management or other clinical applications. Consumers should be cautious about assuming flush-free products deliver the same physiological effects as standard nicotinic acid. Evidence for this form is best characterized as insufficient for most claimed uses beyond basic B3 nutrition.

Preventing Deficiency: Pellagra

Severe niacin deficiency causes pellagra, a disease characterized by dermatitis, diarrhea, and dementia. The ODS grades the evidence that adequate niacin prevents and reverses pellagra as strong. Pellagra is rare in countries with varied food supplies but remains a risk in populations with very restricted diets or certain medical conditions. Food sources including poultry, fish, beef, peanuts, and fortified grains provide niacin equivalents from both preformed niacin and the amino acid tryptophan, which the body can convert to NAD.

Drug Interactions to Know

Two interaction categories are worth highlighting from the ODS data.

• Tuberculosis medications: Isoniazid and pyrazinamide (found in combination drugs such as Rifater) are structural analogs of niacin. They can interrupt niacin production from tryptophan and interfere with niacin's conversion to NAD. Pellagra has occurred in patients on these medications unless niacin intake was increased. Anyone on TB therapy should discuss B3 status with their prescriber.
• Antidiabetes medications: Large doses of nicotinic acid at 1.5 g per day or more can raise blood glucose by causing or aggravating insulin resistance and increasing hepatic glucose production. People taking antidiabetes drugs who also take high-dose nicotinic acid may need blood glucose monitoring and dose adjustments. Always talk to a doctor before combining supplements with medication.

Choosing a Form: A Practical Summary

• For general B3 nutrition at or near the RDA, any form that stays within the 35 mg supplemental UL is reasonable, and dietary sources alone are often sufficient.
• For people sensitive to flushing, nicotinamide is a well-characterized alternative that still supports NAD synthesis.
• For lipid management at pharmacologic doses, nicotinic acid has strong evidence for lipid effects, but this is a medical intervention requiring physician oversight, not a self-care decision.
• For flush-free products containing inositol hexanicotinate, the evidence base is insufficient to confirm equivalence to nicotinic acid for clinical purposes.

A Note on Regulatory Status

These statements have not been evaluated by the FDA. Supplements are not intended to diagnose, treat, cure, or prevent any disease. All figures cited in this guide come from the NIH Office of Dietary Supplements and the National Academies Dietary Reference Intakes report. For personal dosing recommendations, speak with a clinician or pharmacist who knows your full health picture.